https://cancer-enzyme.com/product_info.php?info=p11_brustkrebs-enzym.html
The most common cancer by far in women is breast cancer. In addition to
the 67,300 new cases each year, there are also around 6,000 cases of in
situ tumors. Breast cancer can also affect men - around one percent of
the cases.
Breast cancer incidence rates show that around one in eight women will
develop it at some point in their lives. Around 30 percent of those with
breast cancer were not yet 55 years old when they were diagnosed with
breast cancer.
In the newly-formed German states, the incidence and death rates are
still lower than in the rest of the country, but the number of cases in
women under 55 is now almost the same.
With our breast cancer enzyme No. 4, the spread and growth of cancer
cells in the organism is slowed down. Cancer cells use various
strategies to bypass the body's natural immune defenses. To wander to
other parts of the body undetected, they camouflage themselves with a
cover made of an endogenous substance. However, breast cancer enzyme No.
4 can recognize these cells and destroy them. This effectively prevents
metastases.
Cancer cells can also produce structures that the immune system
classifies as harmful and destroys them. As a result, living cancer
cells remain undetected and can multiply freely. This deception is also
undermined by cancer enzyme. Because the breast cancer enzyme No. 4 can
split these camouflaging structures.
We recommend taking one Vega capsule twice a day.
Keine Kommentare:
Kommentar veröffentlichen